المؤلفون: Hardaker, Elizabeth L., Sanseviero, Emilio, Karmokar, Ankur, Taylor, Devon, Milo, Marta, Michaloglou, Chrysis, Hughes, Adina, Mai, Mimi, King, Matthew, Solanki, Anisha, Magiera, Lukasz, Miragaia, Ricardo, Kar, Gozde, Standifer, Nathan, Surace, Michael, Gill, Shaan, Peter, Alison, Talbot, Sara, Tohumeken, Sehmus, Fryer, Henderson

المصدر: Nature Communications; 2/24/2024, Vol. 15 Issue 1, p1-20, 20p

مصطلحات موضوعية: TUMOR microenvironment, IMMUNE checkpoint inhibitors, TYPE I interferons, MYELOID cells, ATAXIA telangiectasia, CYTOTOXIC T cells

المؤلفون: Kreitman, Robert, Dearden, Claire, Zinzani, Pier Luigi, Delgado, Julio, Karlin, Lionel, Robak, Tadeusz, Gladstone, Douglas, Le Coutre, Philipp, Dietrich, Sascha, Gotic, Mirjana, Larratt, Loree, Offner, Fritz, Schiller, Gary, Swords, Ronan, Bacon, Larry, Bocchia, Monica, Bouabdallah, Krimo, Breems, Dimitri, Cortelezzi, Agostino, Dinner, Shira, Doubek, Michael, Gjertsen, Bjørn Tore, Gobbi, Marco, Hellmann, Andrzej, Leprêtre, Stéphane, Maloisel, Frédéric, Ravandi, Farhad, Rousselot, Philipp, Rummel, Mathias, Siddiqi, Tanya, Tadmor, Tamar, Troussard, Xavier, Yi, Cecilia Arana, Saglio, Giuseppe, Roboz, Gail, Balic, Kemal, Standifer, Nathan, He, Peng, Marshall, Shannon, Wilson, Wyndham, Pastan, Ira, Yao, Nai-Shun, Giles, Francis

المساهمون: National Cancer Institute Bethesda (NCI-NIH), National Institutes of Health Bethesda, MD, USA (NIH), Royal Marsden NHS Foundation Trust, Alma Mater Studiorum Università di Bologna = University of Bologna (UNIBO), Barcelona Centre for International Health Research, Hospital Clinic (CRESIB), Universitat de Barcelona (UB), Service d’Hématologie Centre Hospitalier Lyon Sud - HCL, Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Medical University of Łódź (MUL), Johns Hopkins University (JHU), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Universität Heidelberg Heidelberg = Heidelberg University, Clinical Center of Serbia (KCS), University of Alberta, Universiteit Gent = Ghent University (UGENT), David Geffen School of Medicine Los Angeles, University of California Los Angeles (UCLA), University of California (UC)-University of California (UC), University of Miami Coral Gables, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Università degli Studi di Siena = University of Siena (UNISI), CHU Bordeaux, Ziekenhuis Netwerk Antwerpen (ZNA), Università degli Studi di Milano = University of Milan (UNIMI), Feinberg School of Medicine, Northwestern University Evanston, Faculty of Science Brno (SCI / MUNI), Masaryk University Brno (MUNI), Haukeland University Hospital, University of Bergen (UiB), Ospedale Policlinico San Martino Genoa, Medical University of Gdańsk, Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques (GPMCND), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Clinique Sainte Anne Strasbourg, MD Anderson Cancer Center Houston, The University of Texas Health Science Center at Houston (UTHealth), Infection et inflammation (2I), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Justus-Liebig-Universität Gießen = Justus Liebig University (JLU), City of Hope National Medical Center, Bnai Zion Medical Center Israël, Hôpital Côte de Nacre CHU Caen, CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), The University of New Mexico Albuquerque, Università degli studi di Torino = University of Turin (UNITO), New York Presbyterian Hospital, MedImmune

المصدر: ISSN: 0887-6924.

مصطلحات موضوعية: [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology

العلاقة: hal-02194148; https://normandie-univ.hal.science/hal-02194148Test; https://normandie-univ.hal.science/hal-02194148/documentTest; https://normandie-univ.hal.science/hal-02194148/file/s41375-018-0210-1.pdfTest

الإتاحة: https://doi.org/10.1038/s41375-018-0210-1Test
https://normandie-univ.hal.science/hal-02194148Test
https://normandie-univ.hal.science/hal-02194148/documentTest
https://normandie-univ.hal.science/hal-02194148/file/s41375-018-0210-1.pdfTest

المؤلفون: Naidus, Elliot, Bouquet, Jerome, Oh, David Y., Looney, Timothy J., Yang, Hai, Fong, Lawrence, Standifer, Nathan E., Zhang, Li

المصدر: Cancer Immunology, Immunotherapy; Jul2021, Vol. 70 Issue 7, p2095-2102, 8p

مصطلحات موضوعية: T cells, TREATMENT effectiveness, PROGRAMMED death-ligand 1, NON-small-cell lung carcinoma, OVERALL survival